Abstract
Background: The concept of atopic march was introduced about 15 years ago to define the temporal progression of different allergic conditions, from atopic dermatitis and food allergies in earliest childhood to the development of asthma and allergic rhinitis in older children.
Case Presentation: The authors describe a case report of a young girl who went through the stages of atopic march. The child first showed atopic dermatitis and food allergy in infancy, and, afterwards, she manifested allergic rhinitis and asthma in childhood.
Discussion: This timeline reflects the atopic march's spatial evolution, beginning with the skin and gastrointestinal tract and progressing to the upper and lower airways.
Conclusion: In accord with the most recent evidence, rather than being defined in terms of chronological progression, atopic diseases should be investigated as a spectrum of atopic disorders that might take various developmental paths. According to this theory, the use of Component Resolved Diagnosis in atopic children can be beneficial for highlighting and predicting the atopic profile during the earliest years of life before symptoms arise, helping to stratify the clinical risk and preventing the onset of the atopic march and severe responses.
[1]
Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994; 30(1): 35-9.
[http://dx.doi.org/10.1016/S0190-9622(94)70004-4] [PMID: 8277028]
[http://dx.doi.org/10.1016/S0190-9622(94)70004-4] [PMID: 8277028]
[2]
Gough H, Grabenhenrich L, Reich A, et al. Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MAS. Pediatr Allergy Immunol 2015; 26(5): 431-7.
[http://dx.doi.org/10.1111/pai.12410] [PMID: 26011739]
[http://dx.doi.org/10.1111/pai.12410] [PMID: 26011739]
[3]
Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113(5): 925-31.
[http://dx.doi.org/10.1016/j.jaci.2004.01.778] [PMID: 15131576]
[http://dx.doi.org/10.1016/j.jaci.2004.01.778] [PMID: 15131576]
[4]
Von Kobyletzki LB, Bornehag CG, Hasselgren M, Larsson M, Lindström CB, Svensson Å. Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort. BMC Dermatol 2012; 12(1): 11.
[http://dx.doi.org/10.1186/1471-5945-12-11] [PMID: 22839963]
[http://dx.doi.org/10.1186/1471-5945-12-11] [PMID: 22839963]
[5]
Burgess JA, Dharmage SC, Byrnes GB, et al. Childhood eczema and asthma incidence and persistence: A cohort study from childhood to middle age. J Allergy Clin Immunol 2008; 122(2): 280-5.
[http://dx.doi.org/10.1016/j.jaci.2008.05.018] [PMID: 18572229]
[http://dx.doi.org/10.1016/j.jaci.2008.05.018] [PMID: 18572229]
[6]
Bugiani M, Carosso A, Migliore E, et al. Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy. Allergy 2005; 60(2): 165-70.
[http://dx.doi.org/10.1111/j.1398-9995.2005.00659.x] [PMID: 15647036]
[http://dx.doi.org/10.1111/j.1398-9995.2005.00659.x] [PMID: 15647036]
[7]
Klain A, Indolfi C, Dinardo G, et al. United airway disease. Acta Biomed 2021; 92(S7): e2021526.
[http://dx.doi.org/10.23750/abm.v92iS7.12399]
[http://dx.doi.org/10.23750/abm.v92iS7.12399]
[8]
Manti S, Licari A. How to obtain informed consent for research. Breathe 2018; 14(2): 145-52.
[http://dx.doi.org/10.1183/20734735.001918] [PMID: 29875834]
[http://dx.doi.org/10.1183/20734735.001918] [PMID: 29875834]
[9]
Miraglia del Giudice M, Piacentini GL, Capasso M, et al. Formoterol, montelukast, and budesonide in asthmatic children: Effect on lung function and exhaled nitric oxide. Respir Med 2007; 101(8): 1809-13.
[http://dx.doi.org/10.1016/j.rmed.2007.02.010] [PMID: 17418554]
[http://dx.doi.org/10.1016/j.rmed.2007.02.010] [PMID: 17418554]
[10]
Cipriani F, Mastrorilli C, Tripodi S, et al. Diagnostic relevance of IgE sensitization profiles to eight recombinant Phleum pratense molecules. Allergy 2018; 73(3): 673-82.
[http://dx.doi.org/10.1111/all.13338] [PMID: 29055045]
[http://dx.doi.org/10.1111/all.13338] [PMID: 29055045]
[11]
Leonardi S, Rotolo N, Vitaliti G, Spicuzza L, La Rosa M. IgE values and T-lymphocyte subsets in children with atopic eczema/dermatitis syndrome. Allergy Asthma Proc 2007; 28(5): 529-34.
[http://dx.doi.org/10.2500/aap2007.28.3038] [PMID: 18034970]
[http://dx.doi.org/10.2500/aap2007.28.3038] [PMID: 18034970]
[12]
Bergmann RL, Wahn U, Bergmann KE. The allergy march: From food to pollen. Environ Toxicol Pharmacol 1997; 4(1-2): 79-83.
[http://dx.doi.org/10.1016/S1382-6689(97)10045-X]
[http://dx.doi.org/10.1016/S1382-6689(97)10045-X]
[13]
Manti S, Amorini M, Cuppari C, et al. Filaggrin mutations and Molluscum contagiosum skin infection in patients with atopic dermatitis. Ann Allergy Asthma Immunol 2017; 119(5): 446-51.
[http://dx.doi.org/10.1016/j.anai.2017.07.019] [PMID: 28866311]
[http://dx.doi.org/10.1016/j.anai.2017.07.019] [PMID: 28866311]
[14]
Manti S, Marseglia L, D’Angelo G, et al. “Cumulative stress”: The effects of maternal and neonatal oxidative stress and oxidative stress-inducible genes on programming of atopy. Oxid Med Cell Longev 2016; 2016: 1-7.
[http://dx.doi.org/10.1155/2016/8651820] [PMID: 27504149]
[http://dx.doi.org/10.1155/2016/8651820] [PMID: 27504149]
[15]
Pulvirenti G, Parisi GF, Giallongo A, et al. Lower airway microbiota. Front Pediatr 2019; 7: 393.
[http://dx.doi.org/10.3389/fped.2019.00393] [PMID: 31612122]
[http://dx.doi.org/10.3389/fped.2019.00393] [PMID: 31612122]
[16]
Licari A, Manti S, Marseglia A, et al. Food allergies: Current and future treatments. Medicina 2019; 55(5): 120.
[http://dx.doi.org/10.3390/medicina55050120] [PMID: 31052434]
[http://dx.doi.org/10.3390/medicina55050120] [PMID: 31052434]
[17]
Broeks SA, Brand PLP. Atopic dermatitis is associated with a fivefold increased risk of polysensitisation in children. Acta Paediatr 2017; 106(3): 485-8.
[http://dx.doi.org/10.1111/apa.13729] [PMID: 28027409]
[http://dx.doi.org/10.1111/apa.13729] [PMID: 28027409]
[18]
Just J, Deslandes-Boutmy E, Amat F, et al. Natural history of allergic sensitization in infants with early-onset atopic dermatitis: Results from ORCA Study. Pediatr Allergy Immunol 2014; 25(7): 668-73.
[http://dx.doi.org/10.1111/pai.12287] [PMID: 25283304]
[http://dx.doi.org/10.1111/pai.12287] [PMID: 25283304]
[19]
Dodig S, Čepelak I. The potential of component-resolved diagnosis in laboratory diagnostics of allergy. Biochem Med 2018; 28(2): 020501.
[http://dx.doi.org/10.11613/BM.2018.020501] [PMID: 29666553]
[http://dx.doi.org/10.11613/BM.2018.020501] [PMID: 29666553]
[20]
Martelli A, Calvani M, Foiadelli T, et al. Component resolved diagnosis and risk assessment in food allergy. Acta Biomed 2021; 92(S7): e2021528.
[http://dx.doi.org/10.23750/abm.v92iS7.12421]
[http://dx.doi.org/10.23750/abm.v92iS7.12421]
[21]
Keet C, Plesa M, Szelag D, et al. Ara h 2-specific IgE is superior to whole peanut extract-based serology or skin prick test for diagnosis of peanut allergy in infancy. J Allergy Clin Immunol 2021; 147(3): 977-983.e2.
[http://dx.doi.org/10.1016/j.jaci.2020.11.034] [PMID: 33483152]
[http://dx.doi.org/10.1016/j.jaci.2020.11.034] [PMID: 33483152]
[22]
Kukkonen AK, Pelkonen AS, Mäkinen-Kiljunen S, Voutilainen H, Mäkelä MJ. Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: A double-blind placebo-controlled study. Allergy 2015; 70(10): 1239-45.
[http://dx.doi.org/10.1111/all.12671] [PMID: 26095653]
[http://dx.doi.org/10.1111/all.12671] [PMID: 26095653]
[23]
Krause S, Reese G, Randow S, et al. Lipid transfer protein (Ara h 9) as a new peanut allergen relevant for a Mediterranean allergic population. J Allergy Clin Immunol 2009; 124(4): 771-778.e5.
[http://dx.doi.org/10.1016/j.jaci.2009.06.008] [PMID: 19665774]
[http://dx.doi.org/10.1016/j.jaci.2009.06.008] [PMID: 19665774]
[24]
Ruano-Zaragoza M, Somoza ML, Jiménez-Rodriguez TW, et al. Lipid transfer protein sensitization: Risk of anaphylaxis and molecular sensitization profile in Pru p 3-sensitized patients. Int Arch Allergy Immunol 2021; 182(5): 425-32.
[http://dx.doi.org/10.1159/000511977] [PMID: 33341818]
[http://dx.doi.org/10.1159/000511977] [PMID: 33341818]
[25]
Ibáñez MD, Martínez M, Sánchez JJ, Fernández-Caldas E. [Legume cross-reactivity]. Allergol Immunopathol 2003; 31(3): 151-61.
[PMID: 12783766]
[PMID: 12783766]
[26]
Tran MM, Lefebvre DL, Dharma C, et al. Predicting the atopic march: Results from the canadian healthy infant longitudinal development study. J Allergy Clin Immunol 2018; 141(2): 601-607.e8.
[http://dx.doi.org/10.1016/j.jaci.2017.08.024] [PMID: 29153857]
[http://dx.doi.org/10.1016/j.jaci.2017.08.024] [PMID: 29153857]
[27]
Somanunt S, Chinratanapisit S, Pacharn P, Visitsunthorn N, Jirapongsananuruk O. The natural history of atopic dermatitis and its associa-tion with Atopic March. Asian Pac J Allergy Immunol 2017; 35(3): 137-43.
[PMID: 27996288]
[PMID: 27996288]
[28]
Gustafsson D, Sjöberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis - a prospective follow-up to 7 years of age. Allergy 2000; 55(3): 240-5.
[http://dx.doi.org/10.1034/j.1398-9995.2000.00391.x] [PMID: 10753014]
[http://dx.doi.org/10.1034/j.1398-9995.2000.00391.x] [PMID: 10753014]
[29]
Roduit C, Frei R, Depner M, et al. Phenotypes of atopic dermatitis depending on the timing of onset and progression in childhood. JAMA Pediatr 2017; 171(7): 655-62.
[http://dx.doi.org/10.1001/jamapediatrics.2017.0556] [PMID: 28531273]
[http://dx.doi.org/10.1001/jamapediatrics.2017.0556] [PMID: 28531273]
[30]
Bantz SK, Zhu Z, Zheng T. The atopic march: Progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol 2014; 5(2): 202.
[PMID: 25419479]
[PMID: 25419479]
[31]
Hill DJ, Hosking CS, de Benedictis FM, Oranje AP, Diepgen TL, Bauchau V. Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: An international study. Clin Exp Allergy 2008; 38(1): 161-8.
[PMID: 18028467]
[PMID: 18028467]
[32]
Leonardi S, Cuppari C, Manti S, et al. Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): Association with clinical severity and phenotype. Allergy Asthma Proc 2015; 36(1): 74-81.
[http://dx.doi.org/10.2500/aap.2015.36.3808] [PMID: 25562560]
[http://dx.doi.org/10.2500/aap.2015.36.3808] [PMID: 25562560]
[33]
Kijima A, Murota H. AyaTakahashi, et al. Prevalence and impact of past history of food allergy in atopic dermatitis. Allergol Int 2013; 62(1): 105-12.
[http://dx.doi.org/10.2332/allergolint.12-OA-0468]
[http://dx.doi.org/10.2332/allergolint.12-OA-0468]
[34]
Belgrave DCM, Granell R, Simpson A, et al. Developmental profiles of eczema, wheeze, and rhinitis: Two population-based birth cohort studies. PLoS Med 2014; 11(10): e1001748.
[http://dx.doi.org/10.1371/journal.pmed.1001748] [PMID: 25335105]
[http://dx.doi.org/10.1371/journal.pmed.1001748] [PMID: 25335105]
[35]
Custovic A, Custovic D, Kljaić Bukvić B, Fontanella S, Haider S. Atopic phenotypes and their implication in the atopic march. Expert Rev Clin Immunol 2020; 16(9): 873-81.
[http://dx.doi.org/10.1080/1744666X.2020.1816825] [PMID: 32856959]
[http://dx.doi.org/10.1080/1744666X.2020.1816825] [PMID: 32856959]
[36]
Klain A, Indolfi C, Dinardo G. Atopic march: Is there new evidence? J Pediatric Immunol Allergol 2021; 35(02): 17-22.
[37]
Maiello N, Comberiati P, Giannetti A, Ricci G, Carello R, Galli E. New directions in understanding atopic march starting from atopic der-matitis. Children 2022; 9(4): 450.
[http://dx.doi.org/10.3390/children9040450]
[http://dx.doi.org/10.3390/children9040450]
[38]
Manti S, Leonardi S, Parisi GF, et al. High mobility group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate-severe asthma. Allergy Asthma Proc 2017; 38(3): 197-203.
[http://dx.doi.org/10.2500/aap.2017.38.4047] [PMID: 28441990]
[http://dx.doi.org/10.2500/aap.2017.38.4047] [PMID: 28441990]
[39]
Wendy FD, Donald YML, Lisa AB, et al. Report from the national institute of allergy and infectious diseases workshop on “Atopic der-matitis and the atopic march: Mechanisms and interventions”. J Allergy Clin Immunol 2019; 143(3): 894-913.
[http://dx.doi.org/10.1016/j.jaci.2019.01.003]
[http://dx.doi.org/10.1016/j.jaci.2019.01.003]
Related Journals
